JPS6340190B2 - - Google Patents
Info
- Publication number
- JPS6340190B2 JPS6340190B2 JP54043701A JP4370179A JPS6340190B2 JP S6340190 B2 JPS6340190 B2 JP S6340190B2 JP 54043701 A JP54043701 A JP 54043701A JP 4370179 A JP4370179 A JP 4370179A JP S6340190 B2 JPS6340190 B2 JP S6340190B2
- Authority
- JP
- Japan
- Prior art keywords
- formula
- general formula
- group
- carbon atoms
- same
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000001875 compounds Chemical class 0.000 claims description 25
- 150000003839 salts Chemical class 0.000 claims description 22
- 125000004432 carbon atom Chemical group C* 0.000 claims description 16
- 239000002253 acid Substances 0.000 claims description 14
- 125000002252 acyl group Chemical group 0.000 claims description 13
- -1 nitrogen-containing heterocyclic compound Chemical class 0.000 claims description 10
- 125000000217 alkyl group Chemical group 0.000 claims description 8
- 125000005843 halogen group Chemical group 0.000 claims description 8
- 125000001841 imino group Chemical group [H]N=* 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 6
- 125000003545 alkoxy group Chemical group 0.000 claims description 6
- 229910052739 hydrogen Inorganic materials 0.000 claims description 6
- 239000001257 hydrogen Substances 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 150000007522 mineralic acids Chemical class 0.000 claims description 4
- 150000007524 organic acids Chemical class 0.000 claims description 4
- 229910052717 sulfur Chemical group 0.000 claims description 4
- 125000004434 sulfur atom Chemical group 0.000 claims description 4
- IROXUQCEVYNEGU-UHFFFAOYSA-N 1-(4,5-dihydro-1h-imidazol-2-yl)-1,3-dihydroisoindol-2-amine Chemical compound NN1CC2=CC=CC=C2C1C1=NCCN1 IROXUQCEVYNEGU-UHFFFAOYSA-N 0.000 claims description 3
- OYLPBTPLAUXYTB-UHFFFAOYSA-N 4-chloro-n-(4,5-dihydro-1h-imidazol-2-yl)-1,3-dihydroisoindol-2-amine Chemical compound C1C=2C(Cl)=CC=CC=2CN1NC1=NCCN1 OYLPBTPLAUXYTB-UHFFFAOYSA-N 0.000 claims description 3
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 claims description 3
- 229910052760 oxygen Inorganic materials 0.000 claims description 3
- 239000001301 oxygen Substances 0.000 claims description 3
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 3
- 125000004414 alkyl thio group Chemical group 0.000 claims description 2
- 229910052736 halogen Inorganic materials 0.000 claims description 2
- 150000002367 halogens Chemical class 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 238000002844 melting Methods 0.000 description 18
- 230000008018 melting Effects 0.000 description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 15
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 12
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- 238000000354 decomposition reaction Methods 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- 238000001704 evaporation Methods 0.000 description 6
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 5
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000001530 fumaric acid Substances 0.000 description 4
- 235000011121 sodium hydroxide Nutrition 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- NKWOXRUJRCMCBH-UHFFFAOYSA-N 1,3-dihydroisoindol-2-amine Chemical compound C1=CC=C2CN(N)CC2=C1 NKWOXRUJRCMCBH-UHFFFAOYSA-N 0.000 description 3
- JJWACYUTERPMBM-UHFFFAOYSA-N 1-acetylimidazolidin-2-one Chemical compound CC(=O)N1CCNC1=O JJWACYUTERPMBM-UHFFFAOYSA-N 0.000 description 3
- PZZRSEUDGCFXIH-UHFFFAOYSA-N 2-methylsulfanyl-4,5-dihydro-1h-imidazol-1-ium;iodide Chemical compound I.CSC1=NCCN1 PZZRSEUDGCFXIH-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Chemical compound OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 239000011976 maleic acid Substances 0.000 description 3
- 239000012074 organic phase Substances 0.000 description 3
- LNYXTVUGSBRSIX-UHFFFAOYSA-N 5-chloro-n-(4,5-dihydro-1h-imidazol-2-yl)-1,3-dihydroisoindol-2-amine Chemical compound C1C2=CC(Cl)=CC=C2CN1NC1=NCCN1 LNYXTVUGSBRSIX-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical compound BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical class I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 150000002688 maleic acid derivatives Chemical class 0.000 description 2
- XBQIKUVBLLRHCB-UHFFFAOYSA-N n-(1,3-dihydroisoindol-2-yl)-4,5-dihydro-1,3-oxazol-2-amine Chemical compound O1CCN=C1NN1CC2=CC=CC=C2C1 XBQIKUVBLLRHCB-UHFFFAOYSA-N 0.000 description 2
- JWAXSDXDWQCUAY-UHFFFAOYSA-N n-(4,5-dihydro-1h-imidazol-2-yl)-3,4-dihydro-1h-isoquinolin-2-amine Chemical compound N1CCN=C1NN1CC2=CC=CC=C2CC1 JWAXSDXDWQCUAY-UHFFFAOYSA-N 0.000 description 2
- ODUCDPQEXGNKDN-UHFFFAOYSA-N nitroxyl Chemical compound O=N ODUCDPQEXGNKDN-UHFFFAOYSA-N 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- MJWQKIONDNPIRS-UHFFFAOYSA-N 1,2,4,5-tetrahydro-3-benzazepin-3-amine Chemical compound C1CN(N)CCC2=CC=CC=C21 MJWQKIONDNPIRS-UHFFFAOYSA-N 0.000 description 1
- HMTJXSDKWOSNNA-UHFFFAOYSA-N 1,3,4,5-tetrahydro-2-benzazepin-2-amine Chemical compound C1N(N)CCCC2=CC=CC=C21 HMTJXSDKWOSNNA-UHFFFAOYSA-N 0.000 description 1
- AIKFLHOJAHSLAY-UHFFFAOYSA-N 1,3-dihydroisoindol-2-amine;hydrochloride Chemical compound Cl.C1=CC=C2CN(N)CC2=C1 AIKFLHOJAHSLAY-UHFFFAOYSA-N 0.000 description 1
- QWEVGYHMFWWSMB-UHFFFAOYSA-N 1-(2-chloroethyl)-3-(1,3-dihydroisoindol-2-yl)urea Chemical compound C1=CC=C2CN(NC(=O)NCCCl)CC2=C1 QWEVGYHMFWWSMB-UHFFFAOYSA-N 0.000 description 1
- SRTVEAIOGLPJGL-UHFFFAOYSA-N 1-[2-(1,3-dihydroisoindol-2-ylamino)-4,5-dihydroimidazol-1-yl]ethanone Chemical compound CC(=O)N1CCN=C1NN1CC2=CC=CC=C2C1 SRTVEAIOGLPJGL-UHFFFAOYSA-N 0.000 description 1
- WPMFYLWGIKQTJZ-UHFFFAOYSA-N 1-chloro-2,3-dihydro-1h-isoindole;hydrochloride Chemical compound Cl.C1=CC=C2C(Cl)NCC2=C1 WPMFYLWGIKQTJZ-UHFFFAOYSA-N 0.000 description 1
- BCMYXYHEMGPZJN-UHFFFAOYSA-N 1-chloro-2-isocyanatoethane Chemical compound ClCCN=C=O BCMYXYHEMGPZJN-UHFFFAOYSA-N 0.000 description 1
- ZUWFBQUHBOUPFK-UHFFFAOYSA-N 1-chloro-2-isothiocyanatoethane Chemical compound ClCCN=C=S ZUWFBQUHBOUPFK-UHFFFAOYSA-N 0.000 description 1
- ZGFOBQSQLJDLKV-UHFFFAOYSA-N 1-chloro-3-isothiocyanatopropane Chemical compound ClCCCN=C=S ZGFOBQSQLJDLKV-UHFFFAOYSA-N 0.000 description 1
- IMSODMZESSGVBE-UHFFFAOYSA-N 2-Oxazoline Chemical compound C1CN=CO1 IMSODMZESSGVBE-UHFFFAOYSA-N 0.000 description 1
- IYANYSZUKHQLKL-UHFFFAOYSA-N 3,4-dihydro-1h-isoquinolin-2-amine Chemical compound C1=CC=C2CN(N)CCC2=C1 IYANYSZUKHQLKL-UHFFFAOYSA-N 0.000 description 1
- QISOBCMNUJQOJU-UHFFFAOYSA-N 4-bromo-1h-pyrazole-5-carboxylic acid Chemical compound OC(=O)C=1NN=CC=1Br QISOBCMNUJQOJU-UHFFFAOYSA-N 0.000 description 1
- GLWUDZZJGFTIAY-UHFFFAOYSA-N 5-chloro-1,3-dihydroisoindol-2-amine Chemical compound C1=C(Cl)C=C2CN(N)CC2=C1 GLWUDZZJGFTIAY-UHFFFAOYSA-N 0.000 description 1
- YNTUHDRALXNDEQ-UHFFFAOYSA-N 6-methoxy-2,3,4,5-tetrahydropyridine Chemical compound COC1=NCCCC1 YNTUHDRALXNDEQ-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 239000001089 [(2R)-oxolan-2-yl]methanol Substances 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 150000007514 bases Chemical class 0.000 description 1
- 230000004531 blood pressure lowering effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- GWVMLCQWXVFZCN-UHFFFAOYSA-N isoindoline Chemical compound C1=CC=C2CNCC2=C1 GWVMLCQWXVFZCN-UHFFFAOYSA-N 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 description 1
- GGBJFKPJVFPXLE-UHFFFAOYSA-N n-(1,3-dihydroisoindol-2-yl)-4,5-dihydro-1,3-thiazol-2-amine Chemical compound S1CCN=C1NN1CC2=CC=CC=C2C1 GGBJFKPJVFPXLE-UHFFFAOYSA-N 0.000 description 1
- IZOZFSKJWPKZBB-UHFFFAOYSA-N n-(4,5-dihydro-1h-imidazol-2-yl)-1,2,4,5-tetrahydro-3-benzazepin-3-amine Chemical compound N1CCN=C1NN1CCC2=CC=CC=C2CC1 IZOZFSKJWPKZBB-UHFFFAOYSA-N 0.000 description 1
- LCRYDWXFJJQDPZ-UHFFFAOYSA-N n-(4,5-dihydro-1h-imidazol-2-yl)-1,3,4,5-tetrahydro-2-benzazepin-2-amine Chemical compound N1CCN=C1NN1CC2=CC=CC=C2CCC1 LCRYDWXFJJQDPZ-UHFFFAOYSA-N 0.000 description 1
- JAQWXZPGECEVDQ-UHFFFAOYSA-N n-(4,5-dihydro-1h-imidazol-2-yl)-5,6-dimethoxy-1,3-dihydroisoindol-2-amine Chemical compound C1C=2C=C(OC)C(OC)=CC=2CN1NC1=NCCN1 JAQWXZPGECEVDQ-UHFFFAOYSA-N 0.000 description 1
- GTLFMTKDIQVGMI-UHFFFAOYSA-N n-(4,5-dihydro-1h-imidazol-2-yl)-5,6-dimethyl-1,3-dihydroisoindol-2-amine Chemical compound C1C=2C=C(C)C(C)=CC=2CN1NC1=NCCN1 GTLFMTKDIQVGMI-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000006798 ring closing metathesis reaction Methods 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- BSYVTEYKTMYBMK-UHFFFAOYSA-N tetrahydrofurfuryl alcohol Chemical compound OCC1CCCO1 BSYVTEYKTMYBMK-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19782816627 DE2816627A1 (de) | 1978-04-17 | 1978-04-17 | 2-(n-amino-isoindolinyl)-imidazolin und verfahren zu seiner herstellung |
| DE19792905501 DE2905501A1 (de) | 1979-02-14 | 1979-02-14 | Neue kondensierte, stickstoffhaltige heterocyclische verbindungen und verfahren zu deren herstellung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS54151990A JPS54151990A (en) | 1979-11-29 |
| JPS6340190B2 true JPS6340190B2 (en, 2012) | 1988-08-10 |
Family
ID=25774265
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP4370179A Granted JPS54151990A (en) | 1978-04-17 | 1979-04-12 | Novel condensated nitrogenncontained heterocyclic compound and its manufacture |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US4221798A (en, 2012) |
| JP (1) | JPS54151990A (en, 2012) |
| CH (1) | CH639656A5 (en, 2012) |
| FR (1) | FR2423491A1 (en, 2012) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3133302A1 (de) * | 1981-08-22 | 1983-03-03 | Beiersdorf Ag, 2000 Hamburg | Isoindolin-2-yl-amino-imidazoline und isoindolin-2-yl-guanidine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
| FR2573120B1 (fr) * | 1984-11-14 | 1990-06-22 | Jamison Timothy | Dispositif antivol, en particulier pour cintre de support d'un article vestimentaire. |
| DE3545206A1 (de) * | 1985-12-20 | 1987-06-25 | Beiersdorf Ag | Substituierte 4-fluor-isoindoline, verfahren zu ihrer herstellung und ihre verwendung sowie diese verbindungen enthaltende zubereitungen |
| GB8610909D0 (en) * | 1986-05-03 | 1986-06-11 | Beecham Group Plc | Compounds |
| US5677321A (en) * | 1996-02-29 | 1997-10-14 | Synaptic Pharmaceutical Corporation | 5- and 6-(2-imidazolin-2-ylamino) and -(2-thiazolin-2-ylamino)-benzothiazoles as alpha-2 adrenergic ligands |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB806060A (en) * | 1955-12-19 | 1958-12-17 | Wander Ag Dr A | New imidazoline salts and a process for the production thereof |
| BE704683A (en, 2012) * | 1966-11-07 | 1968-02-15 | ||
| DE1670184A1 (de) * | 1967-01-20 | 1971-01-21 | Boehringer Sohn Ingelheim | Verfahren zur Herstellung heterocyclisch substituierter Hydrazino-imidazoline-(2) |
| US3509170A (en) * | 1967-06-12 | 1970-04-28 | Du Pont | Heterocyclic amino-oxazolines |
| BE757879A (fr) * | 1969-10-24 | 1971-04-22 | Sandoz Sa | Derives du benzo(cd)indole, leur preparation et medicaments contenant ces derives |
| US3666767A (en) * | 1970-01-28 | 1972-05-30 | Warner Lambert Co | 2-amino-1-(2-imidazolin-2-yl)-2-imidazolines |
| US3846412A (en) * | 1971-03-18 | 1974-11-05 | Lepetit Spa | Dihydro-2-amino-isoquinolines and their derivatives |
| DE2220906A1 (de) * | 1972-04-28 | 1973-11-15 | Boehringer Sohn Ingelheim | Neue substituierte 2-phenylaminoimidazoline-(2), deren saeureadditionssalze sowie verfahren zu deren herstellung |
| DE2314985A1 (de) * | 1973-03-26 | 1974-10-17 | Hoechst Ag | 1-(imidazol-1-yl)-isochinoline und verfahren zu ihrer herstellung |
-
1979
- 1979-04-12 JP JP4370179A patent/JPS54151990A/ja active Granted
- 1979-04-13 FR FR7909420A patent/FR2423491A1/fr active Granted
- 1979-04-16 US US06/030,405 patent/US4221798A/en not_active Expired - Lifetime
- 1979-04-17 CH CH361679A patent/CH639656A5/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| FR2423491B1 (en, 2012) | 1981-09-18 |
| JPS54151990A (en) | 1979-11-29 |
| FR2423491A1 (fr) | 1979-11-16 |
| CH639656A5 (de) | 1983-11-30 |
| US4221798A (en) | 1980-09-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3929793A (en) | Certain piperazine-containing indole compounds | |
| US6600047B2 (en) | Process for making amlodipine maleate | |
| US4140793A (en) | Guanidine derivatives | |
| NO151320B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktiv pyrrolidylmetyl-2-metoksy-4-amino-5-isopropyl-sulfonylbenzamider | |
| EP0116769B1 (en) | Dihydropyridines | |
| US4188486A (en) | 2-Substituted benzimidazole compounds | |
| JPH0667919B2 (ja) | 新規なインデノチアゾ−ル誘導体及びその製造法 | |
| FR2537584A1 (fr) | Pyrazoloquinoleines substituees particulieres, procede pour leur preparation, preparations pharmaceutiques contenant ces composes et leur application therapeutique | |
| CA1079277A (en) | 10(.omega.-(BENZOYLPIPERIDINYL)ALKYL) PHENOTHIAZINES | |
| US4292429A (en) | Imidazole urea and amido compounds | |
| JP2004500324A (ja) | ピペラジン環含有化合物の新規の合成及び結晶化 | |
| EP0084993B1 (fr) | Nouveaux dérivés de benzodioxine, leurs procédés de préparation et les compositions pharmaceutiques les renfermant | |
| JPS6340190B2 (en, 2012) | ||
| US5401743A (en) | Aminoalkyl-substituted 2-amino-5-mercaptothiadiazoles the preparation and use thereof | |
| US4064244A (en) | Organic compounds | |
| JPH03106875A (ja) | １―（３―ピリジルメチル）フタラジン誘導体 | |
| JPH0377867A (ja) | 新規オキサゾロピリジン誘導体 | |
| CA2013916A1 (en) | Thiouracil derivatives, pharmaceutical compositions containing them and process for preparing same | |
| JPS62281860A (ja) | アルキレンアミノアルキレン ヘテロ原子基を有するジヒドロ−３，５−ジカルボキシレ−ト | |
| EP0364091B1 (en) | Antipsychotic 4-(4-(3-benzisothiazolyl)-1-piperazinyl)butyl bridged bicyclic imides | |
| JPS6410512B2 (en, 2012) | ||
| JPS62155272A (ja) | 置換４−フルオロ−イソインドリン類、それらの製造方法及び使用並びにそれらの化合物を含有する調合剤 | |
| CZ357190A3 (en) | Dihydropyrimidothiazine derivatives, process of their preparation and pharmaceutical compositions containing thereof | |
| JPH05345765A (ja) | ジベンズアゼピン誘導体 | |
| US3711505A (en) | 2-(2-imidazolin-2-ylthio)-acetanilides |